[
  {
    "date": "2023-12-30",
    "symbol": "STRO",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "STRO",
    "entityregistrantname": "SUTRO BIOPHARMA, INC.",
    "entitycentralindexkey": 1382101,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "001-38662",
    "entitytaxidentificationnumber": "47-0926186",
    "entityaddressaddressline1": "111 Oyster Point Blvd",
    "entityaddresscityortown": "South San Francisco",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94080,
    "cityareacode": 650,
    "localphonenumber": "881-6500",
    "securityexchangename": "NASDAQ",
    "security12btitle": "Common stock, $0.001 par value",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityincorporationstatecountrycode": "DE",
    "entityinteractivedatacurrent": "Yes",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "San Mateo, California",
    "cashandcashequivalentsatcarryingvalue": 69268000,
    "marketablesecuritiescurrent": 264413000,
    "equitysecuritiesfvni": 41937000,
    "accountsreceivablenetcurrent": 36078000,
    "prepaidexpenseandotherassetscurrent": 9846000,
    "assetscurrent": 421542000,
    "propertyplantandequipmentnet": 21940000,
    "operatingleaserightofuseasset": 22815000,
    "otherassetsnoncurrent": 3567000,
    "restrictedcashnoncurrent": 872000,
    "assets": 470736000,
    "accountspayablecurrent": 9440000,
    "accruedliabilitiescurrent": 14686000,
    "contractwithcustomerliabilitycurrent": 20666000,
    "operatingleaseliabilitycurrent": 6420000,
    "debtcurrent": 4061000,
    "accruedexpensesandothercurrentliabilities": 38473000,
    "liabilitiescurrent": 93746000,
    "contractwithcustomerliabilitynoncurrent": 53379000,
    "operatingleaseliabilitynoncurrent": 23154000,
    "deferredroyaltyobligationrelatedtosaleoffutureroyaltiesnoncurrent": 149114000,
    "otherliabilitiesnoncurrent": 1694000,
    "liabilities": 321087000,
    "commonstockvalue": 61000,
    "additionalpaidincapitalcommonstock": 708975000,
    "accumulatedothercomprehensiveincomelossnetoftax": 21000,
    "retainedearningsaccumulateddeficit": -559408000,
    "stockholdersequity": 149649000,
    "liabilitiesandstockholdersequity": 470736000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 300000000,
    "commonstocksharesissued": 61009829,
    "commonstocksharesoutstanding": 61009829,
    "revenuefromcontractwithcustomerexcludingassessedtax": 153731000,
    "researchanddevelopmentexpense": 180425000,
    "generalandadministrativeexpense": 62584000,
    "operatingexpenses": 243009000,
    "operatingincomeloss": -89278000,
    "investmentincomenonoperating": 14510000,
    "equitysecuritiesfvniunrealizedgainloss": 9917000,
    "noncashinterestexpenserelatedtothesaleoffutureroyalties": 12570000,
    "interestandotherincomeexpensenet": -11180000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -88601000,
    "incometaxexpensebenefit": 18192000,
    "netincomeloss": -106793000,
    "earningspersharebasic": -1.78,
    "earningspersharediluted": -1.78,
    "weightedaveragenumberofsharesoutstandingbasic": 60163542,
    "weightedaveragenumberofdilutedsharesoutstanding": 60163542,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 639000,
    "comprehensiveincomenetoftax": -106154000,
    "sharesoutstanding": 61009829,
    "stockissuedduringperiodvaluestockoptionsexercised": 314000,
    "stockissuedduringperiodsharesstockoptionsexercised": 53060,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 2051000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 526079,
    "stockissuedduringperiodvaluerestrictedstockawardnetofforfeitures": 1000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 1155644,
    "adjustmentsrelatedtotaxwithholdingforsharebasedcompensation": 490000,
    "sharespaidfortaxwithholdingforsharebasedcompensation": 81905,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 24908000,
    "stockissuedduringperiodsharesnewissues": 1857410,
    "stockissuedduringperiodvaluethroughatthemarketsale": 2000,
    "stockissuedduringperiodsharesthroughatthemarketsale": 1857410,
    "commonstockissuancecosts": 459000,
    "profitloss": -106793000,
    "depreciationdepletionandamortization": 6816000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 9075000,
    "sharebasedcompensation": 24908000,
    "noncashleaseexpenses": 3628000,
    "noncashinterestexpenseondeferredroyaltyobligation": 12570000,
    "othernoncashincomeexpense": -622000,
    "increasedecreaseinaccountsreceivable": 28956000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -109000,
    "increasedecreaseinaccountspayable": 4812000,
    "increasedecreaseinemployeerelatedliabilities": 1544000,
    "increasedecreaseinaccruedexpensesandotherliabilities": 25300000,
    "increasedecreaseincontractwithcustomerliability": -32599000,
    "increasedecreaseinoperatingleaseliability": -4585000,
    "netcashprovidedbyusedinoperatingactivities": -111616000,
    "paymentstoacquiremarketablesecurities": 460301000,
    "proceedsfrommaturitiesofmarketablesecurities": 434966000,
    "proceedsfromsalesofmarketablesecurities": 25726000,
    "paymentstoacquireequipmentandleaseholdimprovements": 4315000,
    "netcashprovidedbyusedininvestingactivities": -3924000,
    "proceedsfromissuanceofcommonstock": 11971000,
    "repaymentsofdebt": 12500000,
    "proceedsfromsaleoffutureroyaltiesnetofissuancecosts": 136208000,
    "proceedsfromstockoptionsexercised": 314000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 490000,
    "proceedsfromstockplans": 2051000,
    "netcashprovidedbyusedinfinancingactivities": 137554000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 22014000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 70140000,
    "interestpaidnet": 1126000,
    "incometaxespaidnet": 379000,
    "capitalexpendituresincurredbutnotyetpaid": 214000,
    "financingcomponentassociatedwithprogramfees": 9836000,
    "stockreceivedduringperiodshares": 167780,
    "entityincorporationdateofincorporation": "2003-04-21",
    "numberofoperatingsegments": 1,
    "grossproceedsfromissuanceofcommonstock": 12400000,
    "paymentsofstockissuancecosts": 400000,
    "unrestrictedcashcashequivalentsandmarketablesecuritiesatcarryingvalue": 333700000,
    "unrestrictedcashcashequivalentsandequitysecuritiesatcarryingvalue": 41900000,
    "periodfromissuanceofunauditedinterimcondensedfinancialstatements": "P12M",
    "substantialdoubtaboutgoingconcernwithinoneyear": "false",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "2021-07-01",
    "revenueinterestpercentage": 0.04,
    "upfrontpaymentreceived": 140000000,
    "milestonepaymentreceivable": 250000000,
    "propertyplantandequipmentusefullife": "P3Y",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 70140000,
    "assetsfairvaluedisclosure": 56397000,
    "investmentownedbalanceshares": 667780,
    "investmenttypeextensibleenumeration": "http://fasb.org/us-gaap/2023#EquitySecuritiesMember",
    "availableforsaledebtsecuritiesamortizedcostbasis": 56397000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 1000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 28000,
    "availableforsalesecuritiesdebtsecurities": 56397000,
    "cashequivalentsunrealizedgains": -4000,
    "cashandcashequivalentsfairvaluedisclosure": 65148000,
    "marketablesecuritiesmaturityperiod": "P1Y",
    "debtsecuritiesavailableforsaleunrealizedlosspositionaccumulatedloss": 110900000,
    "contractwithcustomerliability": 74045000,
    "revenuerecognizedfromcontingentpaymentnetofwithholdingtax": 5000000,
    "incometaxchargerelatedtocontingentpayment": 500000,
    "contingentpaymentrecognizedasdeferredrevenue": 5000000,
    "withholdingtaxondeferredrevenue": 500000,
    "maximumrefundperiodonterminationofstudy": "P30D",
    "reimbursementsexpensesaccruals": 6900000,
    "reimbursementsexpenses": 8600000,
    "milestonemethodrevenuerecognitiondescription": "If one or more products from the target program is developed for non-oncology or a single indication, the Company will be eligible for reduced aggregate contingent payments. In addition, the Company is eligible to receive tiered royalties ranging from mid-single digit to low teen percentages on the worldwide sales of any commercial products that may result from the collaboration",
    "revenuerecognitionofupfrontpaymentamount": 97500000,
    "maximumamounteligibletoreceivefordevelopmentregulatoryandcommercialmilestonesforeachproductcandidate": 422500000,
    "additionalmilestonepayment": 60000000,
    "upfrontpaymentrevenuenotyetrecognized": 32800000,
    "revenues": 412000,
    "contractwithcustomerliabilityadditions": 11018000,
    "contractwithcustomerliabilitychangeintimeframeperformanceobligationsatisfiedrevenuerecognized": 43617000,
    "revenueremainingperformanceobligation": 20700000,
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionperiod1": "P12M",
    "propertyplantandequipmentgross": 1750000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 42163000,
    "debtinstrumentpaymentterms": "The Term A Loan matured on March 1, 2024 (the “Maturity Date”) and the Company made a final payment of 3.83% of the original principal amount of the Term A Loan on the Maturity Date.",
    "debtinstrumentinterestrateterms": "loan bore interest at the floating per annum rate of interest equal to the greater of (i) 8.07% and (ii) the sum of (a) a specific published 1-month secured overnight financing rate (SOFR) reported on the last business day of the month that immediately precedes the month in which the interest will accrue plus (b) 0.10%, plus (c) 6.40%",
    "amortizationofdebtdiscountpremium": 300000,
    "interestexpensedebt": 1300000,
    "debtinstrumentinterestrateduringperiod": 0.1149,
    "debtinstrumentcarryingamount": 3125000,
    "debtinstrumentunamortizeddiscountpremiumanddebtissuancecostsnet": -936000,
    "longtermdebt": 4061000,
    "longtermdebtcurrent": 4061000,
    "debtinstrumentincludinginterestandfinalpayment": 4126000,
    "debtinstrumentinterestpayable": 43000,
    "debtinstrumentfinalpayment": 958000,
    "lesseeoperatingleaseliabilitypaymentsdue": 36035000,
    "securitydeposit": 900000,
    "operatingleaseexpense": 7000000,
    "operatingleasepayments": 8000000,
    "operatingleaseweightedaverageremainingleaseterm1": "P3Y9M18D",
    "operatingleaseweightedaveragediscountratepercent": 0.108,
    "operatingleasecost": 7039000,
    "shorttermleasecost": 274000,
    "variableleasecost": 2047000,
    "leasecost": 9360000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 9219000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 9533000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 8994000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 8289000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 6461000,
    "operatingleaseliability": 29574000,
    "collaborationandlicenseagreementsandsupplyagreementaccrualscurrent": 6933000,
    "accruedincometaxescurrent": 15165000,
    "otherliabilitiescurrent": 3897000,
    "percentageofinterestrateamortizeliability": 0.17,
    "proceedsfromsaleoffutureroyalties": 140000000,
    "royalityissuancecosts": -3792000,
    "noncashinterestexpenseassociatedwiththesaleoffutureroyalties": 12570000,
    "amortizationofissuancecosts": 336000,
    "commonstockvotingrights": "one vote per share",
    "commonstockcapitalsharesreservedforfutureissuance": 7905032,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 526079,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1777919,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 30000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 11000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1611500,
    "allocatedsharebasedcompensationexpense": 2183000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 7905032,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 964019,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 5717050,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 11.24,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 5.35,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 5.92,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 12.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 12.42,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y7D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y1M20D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 180000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 14000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.807,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.841,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.036,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.047,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 5244873,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 2823725,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 1155644,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 381686,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 8.31,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.41,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 12.31,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 9.92,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "valuationallowancedeferredtaxassetchangeinamount": 36500000,
    "operatinglosscarryforwards": 140200000,
    "taxcreditcarryforwardamount": 20000000,
    "operatinglosscarryforwardsexpirationyear": 2027,
    "taxcreditcarryforwardexpirationyear": 2032,
    "operatinglosscarryforwardslimitationsonuse": "Events which cause limitations in the amount of net operating losses that the Company may utilize in any one year include, but are not limited to, a cumulative ownership change of more than 50%, as defined, over a three-year testing period.",
    "cumulativechangeinownershippercentage": 0.5,
    "periodforcumulativeownershipchange": "P3Y",
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 8700000,
    "currentfederaltaxexpensebenefit": 16646000,
    "currentstateandlocaltaxexpensebenefit": 603000,
    "currentforeigntaxexpensebenefit": 943000,
    "currentincometaxexpensebenefit": 18192000,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.006,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.412,
    "effectiveincometaxratereconciliationtaxcredits": -0.007,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": -0.032,
    "effectiveincometaxratereconciliationfdiipercent": 0.015,
    "effectiveincometaxratereconciliationforeigntaxwithholding": -0.011,
    "effectiveincometaxratereconciliationotheradjustments": 0.037,
    "effectiveincometaxratecontinuingoperations": -0.206,
    "deferredtaxassetsoperatinglosscarryforwards": 37231000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 32800000,
    "deferredtaxassetsinprocessresearchanddevelopment": 46260000,
    "deferredtaxassetsdeferredroyaltyobligation": 31944000,
    "deferredtaxassetsdeferredincome": 15274000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 5309000,
    "deferredtaxassetsoperatingleaseliability": 6335000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 5613000,
    "deferredtaxassetsgross": 180766000,
    "deferredtaxassetsvaluationallowance": 167693000,
    "deferredtaxassetsnet": 13073000,
    "deferredtaxliabilitiesoperatingleaserightofuseasset": 4887000,
    "deferredtaxliabilitiesfixedassets": 809000,
    "deferredtaxliabilitiesinvestments": 7377000,
    "deferredtaxliabilities": 13073000,
    "unrecognizedtaxbenefits": 8730000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 2631000,
    "unrecognizedtaxbenefitsincreasedecreaseresultingfrompriorperiodtaxpositions": -2550000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7905032
  },
  {
    "date": "2022-12-30",
    "symbol": "STRO",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "STRO",
    "entityregistrantname": "SUTRO BIOPHARMA, INC.",
    "entitycentralindexkey": 1382101,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "true",
    "entityfilenumber": "001-38662",
    "entitytaxidentificationnumber": "47-0926186",
    "entityaddressaddressline1": "111 Oyster Point Blvd",
    "entityaddresscityortown": "South San Francisco",
    "entityaddressstateorprovince": "California",
    "entityaddresspostalzipcode": 94080,
    "cityareacode": 650,
    "localphonenumber": "881-6500",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "security12btitle": "Common stock, $0.001 par value",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityincorporationstatecountrycode": "Delaware",
    "entityinteractivedatacurrent": "Yes",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "San Mateo, California",
    "cashandcashequivalentsatcarryingvalue": 43318000,
    "marketablesecuritiescurrent": 255090000,
    "equitysecuritiesfvni": 32000000,
    "accountsreceivablenetcurrent": 7122000,
    "prepaidexpenseandotherassetscurrent": 11667000,
    "assetscurrent": 353153000,
    "propertyplantandequipmentnet": 24621000,
    "operatingleaserightofuseasset": 26443000,
    "otherassetsnoncurrent": 1855000,
    "restrictedcashnoncurrent": 872000,
    "assets": 406944000,
    "accountspayablecurrent": 4797000,
    "accruedliabilitiescurrent": 13142000,
    "contractwithcustomerliabilitycurrent": 16759000,
    "operatingleaseliabilitycurrent": 4585000,
    "debtcurrent": 12500000,
    "accruedexpensesandothercurrentliabilities": 14764000,
    "liabilitiescurrent": 66547000,
    "contractwithcustomerliabilitynoncurrent": 89885000,
    "operatingleaseliabilitynoncurrent": 29574000,
    "longtermdebtnoncurrent": 3771000,
    "otherliabilitiesnoncurrent": 119000,
    "liabilities": 189896000,
    "commonstockvalue": 58000,
    "additionalpaidincapitalcommonstock": 670223000,
    "accumulatedothercomprehensiveincomelossnetoftax": -618000,
    "retainedearningsaccumulateddeficit": -452615000,
    "stockholdersequity": -452615000,
    "liabilitiesandstockholdersequity": 406944000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerexcludingassessedtax": 3828000,
    "researchanddevelopmentexpense": 137171000,
    "generalandadministrativeexpense": 59544000,
    "operatingexpenses": 196715000,
    "operatingincomeloss": -128943000,
    "investmentincomenonoperating": 3455000,
    "equitysecuritiesfvniunrealizedgainloss": 12100000,
    "interestandotherincomeexpensenet": -3346000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -116704000,
    "incometaxexpensebenefit": 2500000,
    "netincomeloss": -119204000,
    "earningspersharebasic": -2.35,
    "earningspersharediluted": -2.35,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -304000,
    "comprehensiveincomenetoftax": -119508000,
    "sharesoutstanding": "null",
    "stockissuedduringperiodvaluestockoptionsexercised": 268000,
    "stockissuedduringperiodsharesstockoptionsexercised": 49654,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 1613000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 270516,
    "stockissuedduringperiodvaluerestrictedstockawardnetofforfeitures": -1000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 620647,
    "adjustmentsrelatedtotaxwithholdingforsharebasedcompensation": 463000,
    "sharespaidfortaxwithholdingforsharebasedcompensation": 53567,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 26304000,
    "stockissuedduringperiodsharesnewissues": "null",
    "stockissuedduringperiodvaluethroughatthemarketsale": 56270000,
    "stockissuedduringperiodsharesthroughatthemarketsale": "null",
    "commonstockissuancecosts": 2026000,
    "profitloss": -119204000,
    "depreciationdepletionandamortization": 5690000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 364000,
    "sharebasedcompensation": 26304000,
    "noncashleaseexpenses": 2598000,
    "equitysecuritiesfvnirealizedgainloss": 4099999.9999999995,
    "remeasurementofliabilityawards": 2000,
    "othernoncashincomeexpense": -326000,
    "increasedecreaseinaccountsreceivable": -5341000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 3544000,
    "increasedecreaseinaccountspayable": -1225000,
    "increasedecreaseinemployeerelatedliabilities": 1725000,
    "increasedecreaseinaccruedexpensesandotherliabilities": 6562000,
    "increasedecreaseincontractwithcustomerliability": 93648000,
    "increasedecreaseinoperatingleaseliability": 1898000,
    "netcashprovidedbyusedinoperatingactivities": 3549000,
    "paymentstoacquiremarketablesecurities": 216671000,
    "proceedsfrommaturitiesofmarketablesecurities": 127960000,
    "proceedsfromsalesofmarketablesecurities": 32799000,
    "proceedsfromsaleofequitysecuritiesfvni": 28739000,
    "paymentstoacquireequipmentandleaseholdimprovements": 7858000,
    "proceedsfromexerciseofoptionsforvaxcyteshares": 9000,
    "netcashprovidedbyusedininvestingactivities": -35022000,
    "proceedsfromissuanceofcommonstock": 56300000,
    "repaymentsofdebt": 9375000,
    "proceedsfromstockoptionsexercised": 268000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 463000,
    "proceedsfromstockplans": 1613000,
    "netcashprovidedbyusedinfinancingactivities": 48313000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 16840000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 48126000,
    "interestpaidnet": 1869000,
    "capitalexpendituresincurredbutnotyetpaid": 280000,
    "financingcomponentassociatedwithprogramfees": 5079000,
    "investmentownedatfairvalue": 7500000,
    "stockreceivedduringperiodshares": 167780,
    "entityincorporationdateofincorporation": "April 21, 2003",
    "numberofoperatingsegments": 1,
    "grossproceedsfromissuanceofcommonstock": 58300000,
    "paymentsofstockissuancecosts": 2000000,
    "unrestrictedcashcashequivalentsandmarketablesecuritiesatcarryingvalue": 302300000,
    "unrestrictedcashcashequivalentsandequitysecuritiesatcarryingvalue": 32000000,
    "periodfromissuanceofunauditedinterimcondensedfinancialstatements": 12,
    "substantialdoubtaboutgoingconcernwithinoneyear": "substantial",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "adopted",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "July 1, 2021",
    "propertyplantandequipmentusefullife": "five years",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 48126000,
    "assetsfairvaluedisclosure": 170673000,
    "investmentownedbalanceshares": 667780,
    "availableforsaledebtsecuritiesamortizedcostbasis": 255708000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 8000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 626000,
    "availableforsalesecuritiesdebtsecurities": 255090000,
    "cashequivalentsunrealizedgains": -2000,
    "cashandcashequivalentsfairvaluedisclosure": 43320000,
    "marketablesecuritiesmaturityperiod": "one year",
    "debtsecuritiesavailableforsaleunrealizedlosspositionaccumulatedloss": 139500000,
    "contingentpaymentreceived": 10000000,
    "milestonepaymentreceived": 2500000,
    "additionalmilestonepaymentreceived": 7500000,
    "contractwithcustomerliability": 17500000,
    "upfrontpaymentreceived": 90000000,
    "contractwithcustomerliabilityrevenuerecognized": 600000,
    "reimbursementsexpensesaccruals": 4800000,
    "reimbursementsexpenses": 12400000,
    "milestonemethodrevenuerecognitiondescription": "If one or more products from the target program is developed for non-oncology or a single indication, the Company will be eligible for reduced aggregate contingent payments. In addition, the Company is eligible to receive tiered royalties ranging from mid-single digit to low teen percentages on the worldwide sales of any commercial products that may result from the collaboration",
    "maximumamounteligibletoreceiveforeachproductdeveloped": 52500000,
    "initiallicensingoptionpayment": 4000000,
    "nonrefundablenoncreditableupfrontpaymentreceivable": 10000000,
    "equityfairvaluedisclosure": 7500000,
    "additionalnonrefundableandnoncreditablepayment": 5000000,
    "maximumamounteligibletoreceivefordevelopmentregulatoryandcommercialmilestonesforeachproductcandidate": 422500000,
    "nonrefundableupfrontpaymentreceivable": 40000000,
    "maximumpotentialpaymentsrelatedtodevelopmentregulatorycommercializationcontingentpaymentsandmilestones": 345000000,
    "additionalmilestonepayment": 60000000,
    "regulatorymilestonescashinpayments": 75000000,
    "upfrontpaymentrevenuenotyetrecognized": 32600000,
    "upfrontpaymentrevenuerecognized": 25000000,
    "upfrontpaymentwithholdingtaxamount": 2500000,
    "numberofinstallments": 2,
    "revenues": 9752000,
    "contractwithcustomerliabilityadditions": 113717000,
    "contractwithcustomerliabilitychangeintimeframeperformanceobligationsatisfiedrevenuerecognized": 12569000,
    "revenueremainingperformanceobligation": 16800000,
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionperiod1": "twelve months",
    "propertyplantandequipmentgross": 62526000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 37905000,
    "debtinstrumentpaymentterms": "The Term A Loan matures on March 1, 2024 (the “Maturity Date”) and was interest-only through March 1, 2022, followed by 24 equal monthly payments of principal and interest.",
    "unrestrictedcashbalance": 10000000,
    "debtinstrumentinterestrateterms": "The Term A Loan will bear interest at a floating per annum rate equal to the greater of (i) 8.07% or (ii) the sum of (a) the greater of (1) the thirty (30) day U.S. LIBOR rate reported in the Wall Street Journal on the last business day of the month that immediately precedes the month in which the interest will accrue or (2) 1.67%, plus (b) 6.40%.",
    "interestpayablecurrentandnoncurrent": 100000,
    "amortizationofdebtdiscountpremium": 500000,
    "interestexpensedebt": 2400000,
    "debtinstrumentinterestrateduringperiod": 0.08720000000000001,
    "debtinstrumentcarryingamount": 15625000,
    "debtinstrumentunamortizeddiscountpremiumanddebtissuancecostsnet": -646000,
    "longtermdebt": 16271000,
    "longtermdebtcurrent": 12500000,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 13312000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 4126000,
    "debtinstrumentincludinginterestandfinalpayment": 17438000,
    "debtinstrumentinterestpayable": 855000,
    "debtinstrumentfinalpayment": 958000,
    "lesseeoperatingleaseliabilitypaymentsdue": 44037000,
    "securitydeposit": 900000,
    "operatingleaseexpense": 6200000,
    "operatingleasepayments": 1700000,
    "operatingleaseweightedaverageremainingleaseterm1": 4.8,
    "operatingleaseweightedaveragediscountratepercent": 0.10800000000000001,
    "operatingleasecost": 6154000,
    "shorttermleasecost": 82000,
    "variableleasecost": 1610000,
    "leasecost": 7846000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 8002000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 9219000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 9533000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 8994000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 8289000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 9878000,
    "operatingleaseliability": 34159000,
    "collaborationandlicenseagreementsandsupplyagreementaccrualscurrent": 2954000,
    "otherliabilitiescurrent": 3080000,
    "commonstockvotingrights": "one vote per share",
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 270516,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 865995,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": " four-year",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 36200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.7,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "allocatedsharebasedcompensationexpense": 26304000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 528321,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 12.68,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 7.16,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 5.4,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 13.54,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 13.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 6.66,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 5.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 2187000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 991000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 0.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.659,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.881,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.038,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 620647,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 512701,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 11.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 7.62,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 17.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 14.44,
    "foreignincometaxexpensebenefitcontinuingoperations": 2500000,
    "valuationallowancedeferredtaxassetchangeinamount": 30600000,
    "operatinglosscarryforwards": 118500000,
    "taxcreditcarryforwardamount": 21300000,
    "operatinglosscarryforwardsexpirationyear": 2030,
    "taxcreditcarryforwardexpirationyear": 2023,
    "operatinglosscarryforwardslimitationsonuse": "Events which cause limitations in the amount of net operating losses that the Company may utilize in any one year include, but are not limited to, a cumulative ownership change of more than 50%, as defined, over a three-year testing period.",
    "cumulativechangeinownershippercentage": 0.5,
    "periodforcumulativeownershipchange": "three-year",
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 8600000,
    "currentforeigntaxexpensebenefit": 2500000,
    "currentincometaxexpensebenefit": 2500000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.262,
    "effectiveincometaxratereconciliationtaxcredits": 0.051,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": -0.032,
    "effectiveincometaxratereconciliationforeigntaxwithholding": -0.021,
    "effectiveincometaxratereconciliationotheradjustments": 0.033,
    "effectiveincometaxratecontinuingoperations": -0.021,
    "deferredtaxassetsoperatinglosscarryforwards": 60952000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 40396000,
    "deferredtaxassetsinprocessresearchanddevelopment": 24481000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 3849000,
    "deferredtaxassetsoperatingleaseliability": 7471000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 4562000,
    "deferredtaxassetsfixedassets": 663000,
    "deferredtaxassetsgross": 142374000,
    "deferredtaxassetsvaluationallowance": 131228000,
    "deferredtaxassetsnet": 11146000,
    "deferredtaxliabilitiesoperatingleaserightofuseasset": 5783000,
    "deferredtaxliabilitiesinvestments": 5363000,
    "deferredtaxliabilities": 11146000,
    "unrecognizedtaxbenefits": 8649000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 2255000,
    "unrecognizedtaxbenefitsincreasedecreaseresultingfrompriorperiodtaxpositions": 15000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null"
  },
  {
    "date": "2021-12-30",
    "symbol": "STRO",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "STRO",
    "entityregistrantname": "SUTRO BIOPHARMA, INC.",
    "entitycentralindexkey": 1382101,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Large accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "true",
    "entityfilenumber": "001-38662",
    "entitytaxidentificationnumber": "47-0926186",
    "entityaddressaddressline1": "111 Oyster Point Blvd",
    "entityaddresscityortown": "South San Francisco",
    "entityaddressstateorprovince": "California",
    "entityaddresspostalzipcode": 94080,
    "cityareacode": 650,
    "localphonenumber": "881-6500",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "security12btitle": "Common stock, $0.001 par value",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityincorporationstatecountrycode": "Delaware",
    "entityinteractivedatacurrent": "Yes",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Redwood City, California",
    "cashandcashequivalentsatcarryingvalue": 29451000,
    "marketablesecuritiescurrent": 130343000,
    "equitysecuritiesfvni": 37200000,
    "accountsreceivablenetcurrent": 12454000,
    "prepaidexpenseandotherassetscurrent": 8123000,
    "assetscurrent": 218515000,
    "propertyplantandequipmentnet": 22550000,
    "operatingleaserightofuseasset": 29041000,
    "marketablesecuritiesnoncurrent": 68775000,
    "otherassetsnoncurrent": 1655000,
    "restrictedcashnoncurrent": 872000,
    "assets": 341408000,
    "accountspayablecurrent": 11327000,
    "accruedliabilitiescurrent": 11417000,
    "contractwithcustomerliabilitycurrent": 5496000,
    "operatingleaseliabilitycurrent": 1037000,
    "debtcurrent": 9375000,
    "otherliabilitiescurrent": 3084000,
    "liabilitiescurrent": 41736000,
    "operatingleaseliabilitynoncurrent": 31224000,
    "longtermdebtnoncurrent": 15738000,
    "otherliabilitiesnoncurrent": 146000,
    "liabilities": 88844000,
    "commonstockvalue": 46000,
    "additionalpaidincapitalcommonstock": 586243000,
    "accumulatedothercomprehensiveincomelossnetoftax": -314000,
    "retainedearningsaccumulateddeficit": -333411000,
    "stockholdersequity": -333411000,
    "liabilitiesandstockholdersequity": 341408000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerexcludingassessedtax": 3041000,
    "researchanddevelopmentexpense": 104400000,
    "generalandadministrativeexpense": 56004000,
    "operatingexpenses": 160404000,
    "operatingincomeloss": -98524000,
    "investmentincomenonoperating": 577000,
    "equitysecuritiesfvniunrealizedgainloss": 9000,
    "interestandotherexpensenet": 3137000,
    "netincomeloss": -105538000,
    "earningspersharebasicanddiluted": -2.29,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -443000,
    "comprehensiveincomenetoftax": -105981000,
    "sharesoutstanding": "null",
    "stockissuedduringperiodsharesstockoptionsexercised": 262279,
    "stockissuedduringperiodvaluestockoptionsandwarrantsexercised": 2485000,
    "stockissuedduringperiodsharesstockoptionsandwarrantsexercised": 246678,
    "stockrepurchasedandretiredduringperiodvalue": 7000,
    "stockrepurchasedandretiredduringperiodshares": 7687,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 1765000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 145809,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 238724,
    "adjustmentsrelatedtotaxwithholdingforsharebasedcompensation": 987000,
    "sharespaidfortaxwithholdingforsharebasedcompensation": 48509,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 23241000,
    "profitloss": -105538000,
    "depreciationdepletionandamortization": 4844000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -2781000,
    "sharebasedcompensation": 23241000,
    "noncashleaseexpenses": 4929000,
    "remeasurementofliabilityawards": 12000,
    "othernoncashincomeexpense": -1242000,
    "increasedecreaseinaccountsreceivable": 6895000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 3959000,
    "increasedecreaseinaccountspayable": 6433000,
    "increasedecreaseinemployeerelatedliabilities": 2594000,
    "increasedecreaseinotheroperatingliabilities": 2141000,
    "increasedecreaseincontractwithcustomerliability": -15207000,
    "increasedecreaseinoperatingleaseliability": -2727000,
    "netcashprovidedbyusedinoperatingactivities": -81679000,
    "paymentstoacquiremarketablesecurities": 248727000,
    "proceedsfrommaturitiesofmarketablesecurities": 148250000,
    "proceedsfromsalesofmarketablesecurities": 18476000,
    "paymentstoacquireequipmentandleaseholdimprovements": 15323000,
    "proceedsfromexerciseofoptionsforvaxcyteshares": 9000,
    "netcashprovidedbyusedininvestingactivities": -97315000,
    "proceedsfromstockoptionsexercised": 2485000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 987000,
    "paymentsforrepurchaseofcommonstock": 7000,
    "proceedsfromstockplans": 1765000,
    "netcashprovidedbyusedinfinancingactivities": 3256000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -175738000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 31286000,
    "interestpaidnet": 2046000,
    "incometaxespaidnet": 103000,
    "capitalexpendituresincurredbutnotyetpaid": 370000,
    "remeasurementofoperatingleaserightofuseassetsforleasemodification": 4227000,
    "embeddedinterestassociatedwithprogramfees": 610000,
    "entityincorporationdateofincorporation": "April 21, 2003",
    "numberofoperatingsegments": 1,
    "unrestrictedcashcashequivalentsandmarketablesecuritiesatcarryingvalue": 229500000,
    "periodfromissuanceofunauditedinterimcondensedfinancialstatements": 12,
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "adopted",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2019",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "no",
    "propertyplantandequipmentusefullife": "five years",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 31286000,
    "assetsfairvaluedisclosure": 151698000,
    "investmentownedbalanceshares": "null",
    "availableforsaledebtsecuritiesamortizedcostbasis": 199432000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 314000,
    "availableforsalesecuritiesdebtsecurities": 199118000,
    "cashandcashequivalentsfairvaluedisclosure": 29451000,
    "marketablesecuritiesmaturityperiod": "one year",
    "debtsecuritiesavailableforsaleunrealizedlosspositionaccumulatedloss": 176500000,
    "contingentpaymentreceived": 15000000,
    "milestonepaymentreceived": 2500000,
    "additionalmilestonepaymentreceived": 7500000,
    "contractwithcustomerliability": 4000000,
    "remainingcontingentpaymentreceived": 300000,
    "upfrontpaymentreceived": 60000000,
    "unearnedrevenue": 7300000,
    "constrainedvariableconsideration": 7500000,
    "contractwithcustomerliabilityrevenuerecognized": 1900000,
    "reimbursementsexpenses": 8900000,
    "revenuerecognitionaggregatecontingentpaymentseligibletoreceive": 500000000,
    "milestonemethodrevenuerecognitiondescription": "If one or more products from the target program is developed for non-oncology or a single indication, the Company will be eligible for reduced aggregate milestone payments. In addition, the Company is eligible to receive tiered royalties ranging from mid-single digit to low teen percentages on the worldwide sales of any commercial products that may result from the collaboration",
    "maximumamounteligibletoreceiveforeachproductdeveloped": 52500000,
    "nonrefundableupfrontpaymentreceivable": 40000000,
    "maximumpotentialpaymentsrelatedtodevelopmentregulatorycommercializationcontingentpaymentsandmilestones": 345000000,
    "revenues": 11483000,
    "contractwithcustomerliabilityadditions": 23402000,
    "contractwithcustomerliabilitychangeintimeframeperformanceobligationsatisfiedrevenuerecognized": 38609000,
    "revenueremainingperformanceobligation": 5500000,
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionperiod1": "twelve months",
    "propertyplantandequipmentgross": 55976000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 33426000,
    "debtinstrumentpaymentterms": "The Term A Loan matures on March 1, 2024 (the “Maturity Date”) and will be interest-only through March 1, 2022, followed by 24 equal monthly payments of principal and interest.",
    "debtinstrumentfrequencyofperiodicpayment": "monthly payments",
    "debtinstrumentinterestrateterms": "The Term A Loan will bear interest at a floating per annum rate equal to the greater of (i) 8.07% or (ii) the sum of (a) the greater of (1) the thirty (30) day U.S. LIBOR rate reported in the Wall Street Journal on the last business day of the month that immediately precedes the month in which the interest will accrue or (2) 1.67%, plus (b) 6.40%.",
    "interestpayablecurrentandnoncurrent": 200000,
    "amortizationofdebtdiscountpremium": 600000,
    "interestexpensedebt": 2600000,
    "debtinstrumentinterestrateduringperiod": 0.08070000000000001,
    "debtinstrumentcarryingamount": 25000000,
    "debtinstrumentunamortizeddiscountpremiumanddebtissuancecostsnet": -113000,
    "longtermdebt": 25113000,
    "longtermdebtcurrent": 9375000,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 11166000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 13312000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 4126000,
    "debtinstrumentincludinginterestandfinalpayment": 28604000,
    "debtinstrumentinterestpayable": 2646000,
    "debtinstrumentfinalpayment": 958000,
    "lesseeoperatingleaseliabilitypaymentsdue": 45694000,
    "securitydeposit": 900000,
    "operatingleaseexpense": 8400000,
    "operatingleasepayments": 6200000,
    "operatingleaseweightedaverageremainingleaseterm1": 5.7,
    "operatingleaseweightedaveragediscountratepercent": 0.10800000000000001,
    "operatingleasecost": 8355000,
    "shorttermleasecost": 117000,
    "variableleasecost": 2089000,
    "leasecost": 10561000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1657000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 8002000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 9219000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 9533000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 8994000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 8289000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 13433000,
    "operatingleaseliability": 32261000,
    "potentialfinancialbenefitbaserentabatement": 5200000,
    "baserentabatementsubleaseperiod": 18,
    "commonstockvotingrights": "one vote per share",
    "classofwarrantorrighstdatefromwhichwarrantsorrightsexercisable": "December 31, 2020",
    "commonstockcapitalsharesreservedforfutureissuance": 266724,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 145809,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 673251,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 2800000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 14.24,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": " four-year",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 36300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 3.2,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 266724,
    "allocatedsharebasedcompensationexpense": 97000,
    "othernonoperatingincomeexpense": 109000,
    "liabilityattributabletocalloptionplan": 97000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 139673,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 13.86,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 20.27,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 10.47,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 10.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 12.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 7.39,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 6.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 14955000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 9170000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 0.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.659,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 1.114,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.006,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.013000000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 238724,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 118075,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 18.43,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 20.31,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 11.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 17.66,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 4445,
    "valuationallowancedeferredtaxassetchangeinamount": 26200000,
    "operatinglosscarryforwards": 109200000,
    "taxcreditcarryforwardamount": 17200000,
    "operatinglosscarryforwardsexpirationyear": 2030,
    "taxcreditcarryforwardexpirationyear": 2023,
    "operatinglosscarryforwardslimitationsonuse": "Events which cause limitations in the amount of net operating losses that the Company may utilize in any one year include, but are not limited to, a cumulative ownership change of more than 50%, as defined, over a three-year testing period.",
    "cumulativechangeinownershippercentage": 0.5,
    "periodforcumulativeownershipchange": "three-year",
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 6400000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.247,
    "effectiveincometaxratereconciliationtaxcredits": 0.037000000000000005,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": -0.002,
    "effectiveincometaxratereconciliationotheradjustments": 0.002,
    "deferredtaxassetsoperatinglosscarryforwards": 67719000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 31864000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 3973000,
    "deferredtaxassetsoperatingleaseliability": 7266000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 3910000,
    "deferredtaxassetsfixedassets": 1008000,
    "deferredtaxassetsgross": 115740000,
    "deferredtaxassetsvaluationallowance": 100646000,
    "deferredtaxassetsnet": 15094000,
    "deferredtaxliabilitiesoperatingleaserightofuseasset": 6716000,
    "deferredtaxliabilitiesinvestments": 8378000,
    "deferredtaxliabilities": 15094000,
    "unrecognizedtaxbenefits": 6409000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1492000,
    "unrecognizedtaxbenefitsincreasedecreaseresultingfrompriorperiodtaxpositions": 15000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null"
  },
  {
    "date": "2020-12-30",
    "symbol": "STRO",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2020",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "STRO",
    "entityregistrantname": "SUTRO BIOPHARMA, INC.",
    "entitycentralindexkey": 1382101,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "001-38662",
    "entitytaxidentificationnumber": "47-0926186",
    "entityaddressaddressline1": "310 Utah Avenue",
    "entityaddressaddressline2": "Suite 150",
    "entityaddresscityortown": "South San Francisco",
    "entityaddressstateorprovince": "California",
    "entityaddresspostalzipcode": 94080,
    "cityareacode": 650,
    "localphonenumber": "392-8412",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "security12btitle": "Common stock, $0.001 par value",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityincorporationstatecountrycode": "Delaware",
    "entityinteractivedatacurrent": "Yes",
    "cashandcashequivalentsatcarryingvalue": 204632000,
    "marketablesecuritiescurrent": 120341000,
    "equitysecuritiesfvni": 41600000,
    "accountsreceivablenetcurrent": 5559000,
    "prepaidexpenseandotherassetscurrent": 4486000,
    "assetscurrent": 378182000,
    "propertyplantandequipmentnet": 12935000,
    "otherassetsnoncurrent": 2122000,
    "restrictedcashnoncurrent": 872000,
    "assets": 394111000,
    "accountspayablecurrent": 5544000,
    "accruedliabilitiescurrent": 8823000,
    "contractwithcustomerliabilitycurrent": 14603000,
    "otherliabilitiescurrent": 627000,
    "liabilitiescurrent": 29597000,
    "contractwithcustomerliabilitynoncurrent": 6100000,
    "deferredrentcreditnoncurrent": 1340000,
    "longtermdebtnoncurrent": 25000000,
    "otherliabilitiesnoncurrent": 481000,
    "liabilities": 62063000,
    "commonstockvalue": 46000,
    "additionalpaidincapitalcommonstock": 559746000,
    "accumulatedothercomprehensiveincomelossnetoftax": 129000,
    "retainedearningsaccumulateddeficit": -227873000,
    "stockholdersequity": -227873000,
    "liabilitiesandstockholdersequity": 394111000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerexcludingassessedtax": 42722000,
    "researchanddevelopmentexpense": 76961000,
    "generalandadministrativeexpense": 36818000,
    "operatingexpenses": 113779000,
    "operatingincomeloss": -71057000,
    "investmentincomenonoperating": 1508000,
    "equitysecuritiesfvniunrealizedgainloss": 100000,
    "interestandotherexpensenet": 4077000,
    "netincomeloss": -32128000,
    "earningspersharebasicanddiluted": -0.99,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "revenuefromrelatedparties": 2813000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -36000,
    "comprehensiveincomenetoftax": -32164000,
    "sharesoutstanding": "null",
    "stockissuedduringperiodvaluestockoptionsexercised": 1861000,
    "stockissuedduringperiodsharesstockoptionsexercised": 257834,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 1285000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 195992,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 151976,
    "adjustmentsrelatedtotaxwithholdingforsharebasedcompensation": 314000,
    "sharespaidfortaxwithholdingforsharebasedcompensation": 30461,
    "stockissuedduringperiodvaluenewissues": 227252000,
    "stockissuedduringperiodsharesnewissues": "null",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 11917000,
    "warrantsissuedduringperiodvalueinconnectionwithdebtrefinancing": 619000,
    "stockissuedduringperiodvaluethroughatthemarketsale": 23803000,
    "stockissuedduringperiodsharesthroughatthemarketsale": "null",
    "commonstockissuancecosts": 777000,
    "profitloss": 1100000,
    "depreciationdepletionandamortization": 4297000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -490000,
    "sharebasedcompensation": 11917000,
    "remeasurementofliabilityawards": -19000,
    "othernoncashincomeexpense": -587000,
    "increasedecreaseinaccountsreceivable": -739000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 80000,
    "increasedecreaseinaccountspayable": -947000,
    "increasedecreaseinemployeerelatedliabilities": 2806000,
    "increasedecreaseinotheroperatingliabilities": 22000,
    "increasedecreaseindeferredcharges": -931000,
    "increasedecreaseincontractwithcustomerliability": -14957000,
    "netcashprovidedbyusedinoperatingactivities": -67802000,
    "paymentstoacquiremarketablesecurities": 130741000,
    "proceedsfrommaturitiesofmarketablesecurities": 116385000,
    "proceedsfromsalesofmarketablesecurities": 22000000,
    "paymentstoacquireequipmentandleaseholdimprovements": 7129000,
    "proceedsfromexerciseofoptionsforvaxcyteshares": 89000,
    "netcashprovidedbyusedininvestingactivities": 604000,
    "proceedsfromissuanceofcommonstock": 23800000,
    "proceedsfromissuanceofdebt": 25000000,
    "repaymentsofdebt": 10000000,
    "proceedsfromstockoptionsexercised": 1861000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 314000,
    "proceedsfromstockplans": 1285000,
    "netcashprovidedbyusedinfinancingactivities": 269247000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 202049000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 207024000,
    "interestpaidnet": 1675000,
    "capitalexpendituresincurredbutnotyetpaid": 546000,
    "offeringcostsincludedinaccountspayable": 361000,
    "embeddedinterestassociatedwithprogramfees": 1852000,
    "warrantsissuedtolenders": 619000,
    "entityincorporationdateofincorporation": "April 21, 2003",
    "numberofoperatingsegments": 1,
    "grossproceedsfromissuanceofcommonstock": 24600000,
    "paymentsofstockissuancecosts": 800000,
    "unrestrictedcashcashequivalentsandmarketablesecuritiesatcarryingvalue": 326500000,
    "periodfromissuanceofunauditedinterimcondensedfinancialstatements": 12,
    "substantialdoubtaboutgoingconcernwithinoneyear": "false",
    "upfrontpaymentreceived": 60000000,
    "increaseinrevenueduetoadjustments": 1100000,
    "earningspersharebasic": 0.03,
    "earningspersharediluted": 0.03,
    "propertyplantandequipmentusefullife": "five years",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 207024000,
    "assetsfairvaluedisclosure": 80556000,
    "investmentownedbalanceshares": "null",
    "availableforsaledebtsecuritiesamortizedcostbasis": 120213000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 131000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 3000,
    "availableforsalesecuritiesdebtsecurities": 120341000,
    "cashandcashequivalentsfairvaluedisclosure": 204632000,
    "marketablesecuritiesmaturityperiod": "one year",
    "availableforsalesecuritiescontinuousunrealizedlosspositionaccumulatedloss": 14700000,
    "contractwithcustomerliability": 1000000,
    "contractwithcustomerliabilityadditions": 9786000,
    "contractwithcustomerliabilityrevenuerecognized": 24743000,
    "revenueremainingperformanceobligation": 14600000,
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionperiod1": "twelve months",
    "revenues": 200000,
    "relatedpartytransactionotherrevenuesfromtransactionswithrelatedparty": 7800000,
    "unearnedrevenue": 7300000,
    "embeddedinterestassociatedwithupfrontpayment": 1900000,
    "ftefundingreceived": 5500000,
    "revenuerecognitionaggregatecontingentpaymentseligibletoreceive": 500000000,
    "milestonemethodrevenuerecognitiondescription": "If one or more products from each of the target programs are developed for non-oncology or a single indication, the Company will be eligible for reduced aggregate milestone payments. In addition, the Company is eligible to receive tiered royalties ranging from mid-single digit to low teen percentages on the worldwide sales of any commercial products that may result from the collaboration.",
    "maximumamounteligibletoreceiveforeachproductdeveloped": 52500000,
    "increasedecreaseindeferredrevenue": 600000,
    "researchdevelopmentandcommercializationagreementterminationperiod": 12,
    "researchdevelopmentandcommercializationagreementterminationdescription": "The LLS Agreement terminates upon the earlier of (a) fulfillment of all payment obligations by both parties or (b) 12 years after the effective date.  LLS may terminate the LLS Agreement at any time with 60 days’ prior written notice. Either the Company or LLS has the right to terminate the LLS Agreement based on the other party’s uncured material breach.",
    "convertiblepreferredstockwarrantliabilityfairvalue": 200000,
    "propertyplantandequipmentgross": 49762000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 36827000,
    "debtinstrumentpaymentterms": "The Term Loans mature on March 1, 2024 (the “Maturity Date”) and will be interest-only through March 1, 2022, followed by 24 equal monthly payments of principal and interest.",
    "debtinstrumentfrequencyofperiodicpayment": "monthly payments",
    "debtinstrumentinterestrateterms": "The Term Loans will bear interest at a floating per annum rate equal to the greater of (i) 8.07% or (ii) the sum of (a) the greater of (1) the thirty (30) day U.S. LIBOR rate reported in the Wall Street Journal on the last business day of the month that immediately precedes the month in which the interest will accrue or (2) 1.67%, plus (b) 6.40%.",
    "dateofloanlapsed": "December 31, 2020",
    "interestpayablecurrentandnoncurrent": 200000,
    "amortizationofdebtdiscountpremium": 500000,
    "interestexpensedebt": 2300000,
    "debtinstrumentinterestrateduringperiod": 0.0808,
    "lesseeoperatingleaseoptiontoextend": "two three-year options to extend the lease term",
    "operatingleasesrentexpensenet": 4700,
    "lesseeoperatingleasesandsubleaseliabilitypaymentsduenexttwelvemonths": 5742000,
    "lesseeoperatingleasesandsubleaseliabilitypaymentsdueyeartwo": 5183000,
    "lesseeoperatingleasesandsubleaseliabilitypaymentsdueyearthree": 6310000,
    "lesseeoperatingleasesandsubleaseliabilitypaymentsdueyearfour": 7476000,
    "lesseeoperatingleasesandsubleaseliabilitypaymentsdueyearfiveandthereafter": 24034000,
    "lesseeoperatingleasesandsubleaseliabilitypaymentsdue": 48745000,
    "potentialfinancialbenefitbaserentabatement": 5200,
    "baserentabatementsubleaseperiod": "P18M",
    "commonstockvotingrights": "one vote per share",
    "commonstockcapitalsharesreservedforfutureissuance": 266724,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 361539,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 195992,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 1200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.59,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 5100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.7,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 266724,
    "allocatedsharebasedcompensationexpense": 109000,
    "othernonoperatingincomeexpense": 76000,
    "liabilityattributabletocalloptionplan": 109000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 118093,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 11.93,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 9.7,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 10.86,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 12.47,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y9M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y10M2D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 53202000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 24285000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 1.114,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.019,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 666375,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 530250,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 151976,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 47698,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 9.83,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 8.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 14.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 8.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 8890,
    "incometaxexpensebenefit": 100000,
    "valuationallowancedeferredtaxassetchangeinamount": 11100000,
    "operatinglosscarryforwards": 90800000,
    "taxcreditcarryforwardamount": 13900000,
    "operatinglosscarryforwardsexpirationyear": 2030,
    "taxcreditcarryforwardexpirationyear": 2023,
    "operatinglosscarryforwardslimitationsonuse": "Events which cause limitations in the amount of net operating losses that the Company may utilize in any one year include, but are not limited to, a cumulative ownership change of more than 50%, as defined, over a three-year testing period.",
    "cumulativechangeinownershippercentage": 0.5,
    "periodforcumulativeownershipchange": "P3Y",
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 4900000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.34700000000000003,
    "effectiveincometaxratereconciliationtaxcredits": 0.09300000000000001,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": -0.019,
    "effectiveincometaxratereconciliationotheradjustments": 0.061,
    "effectiveincometaxratecontinuingoperations": -0.003,
    "deferredtaxassetsoperatinglosscarryforwards": 47549000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 25175000,
    "deferredtaxassetsdeferredincome": 3629000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 6460000,
    "deferredtaxassetsfixedassets": 917000,
    "deferredtaxassetsgross": 83730000,
    "deferredtaxliabilitiesinvestments": 9298000,
    "deferredtaxliabilities": 9298000,
    "deferredtaxassetsvaluationallowance": 74432000,
    "unrecognizedtaxbenefits": 4902000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1090000,
    "unrecognizedtaxbenefitsincreasedecreaseresultingfrompriorperiodtaxpositions": 29000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null"
  },
  {
    "date": "2019-12-30",
    "symbol": "STRO",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2019",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "STRO",
    "entityregistrantname": "SUTRO BIOPHARMA, INC.",
    "entitycentralindexkey": 1382101,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "001-38662",
    "entitytaxidentificationnumber": "47-0926186",
    "entityaddressaddressline1": "310 Utah Avenue",
    "entityaddressaddressline2": "Suite 150",
    "entityaddresscityortown": "South San Francisco",
    "entityaddressstateorprovince": "California",
    "entityaddresspostalzipcode": 94080,
    "cityareacode": 650,
    "localphonenumber": "392-8412",
    "securityexchangename": "Nasdaq Global Market",
    "security12btitle": "Common stock, $0.001 par value",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityincorporationstatecountrycode": "Delaware",
    "entityinteractivedatacurrent": "Yes",
    "cashandcashequivalentsatcarryingvalue": 3151000,
    "marketablesecuritiescurrent": 112904000,
    "accountsreceivablenetcurrent": 14000,
    "prepaidexpenseandotherassetscurrent": 4406000,
    "assetscurrent": 128568000,
    "propertyplantandequipmentnet": 9633000,
    "marketablesecuritiesnoncurrent": 15609000,
    "otherassetsnoncurrent": 2545000,
    "restrictedcashnoncurrent": 15000,
    "assets": 156370000,
    "accountspayablecurrent": 5584000,
    "accruedliabilitiescurrent": 6017000,
    "contractwithcustomerliabilitycurrent": -2524000,
    "debtcurrent": 1000000,
    "otherliabilitiescurrent": 901000,
    "liabilitiescurrent": 32967000,
    "contractwithcustomerliabilitynoncurrent": -3911000,
    "deferredrentcreditnoncurrent": 409000,
    "longtermdebtnoncurrent": 8900000,
    "otherliabilitiesnoncurrent": 134000,
    "liabilities": -6435000,
    "commonstockvalue": 23000,
    "additionalpaidincapitalcommonstock": 293346000,
    "accumulatedothercomprehensiveincomelossnetoftax": 165000,
    "retainedearningsaccumulateddeficit": -6435000,
    "stockholdersequity": -195745000,
    "liabilitiesandstockholdersequity": 156370000,
    "accountsreceivablerelatedpartiescurrent": 14000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerexcludingassessedtax": 3900000,
    "researchanddevelopmentexpense": 65612000,
    "generalandadministrativeexpense": 32592000,
    "operatingexpenses": 98204000,
    "operatingincomeloss": -55468000,
    "investmentincomenonoperating": 4074000,
    "interestandotherincomeexpensenet": -4350000,
    "netincomeloss": -55744000,
    "earningspersharebasicanddiluted": -2.43,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "revenuefromrelatedparties": 8900000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 212000,
    "comprehensiveincomenetoftax": -55532000,
    "sharesoutstanding": "null",
    "cumulativeeffectofnewaccountingprincipleinperiodofadoption": 10327000,
    "stockissuedduringperiodvaluestockoptionsexercised": 180000,
    "stockissuedduringperiodsharesstockoptionsexercised": 7500,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 1260000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 131939,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 114103,
    "adjustmentsrelatedtotaxwithholdingforsharebasedcompensation": 297000,
    "sharespaidfortaxwithholdingforsharebasedcompensation": 30461,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 10312000,
    "temporaryequityissuancecosts": 644000,
    "commonstockissuancecosts": 10564000,
    "profitloss": 3892000,
    "depreciationdepletionandamortization": 4777000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 1457000,
    "sharebasedcompensation": 10312000,
    "unrealizedgainlossonderivativesandcommoditycontracts": 115000,
    "gainlossondispositionofassets1": -275000,
    "othernoncashincomeexpense": -193000,
    "increasedecreaseinaccountsreceivable": 3809000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1441000,
    "increasedecreaseinaccountspayable": 2253000,
    "increasedecreaseinemployeerelatedliabilities": -200000,
    "increasedecreaseinotheroperatingliabilities": 186000,
    "increasedecreaseindeferredcharges": 67000,
    "increasedecreaseincontractwithcustomerliability": -20186000,
    "netcashprovidedbyusedinoperatingactivities": -65023000,
    "paymentstoacquiremarketablesecurities": 196226000,
    "proceedsfrommaturitiesofmarketablesecurities": 128576000,
    "proceedsfromsalesofmarketablesecurities": 20000000,
    "paymentstoacquireequipmentandleaseholdimprovements": 3481000,
    "netcashprovidedbyusedininvestingactivities": -51131000,
    "repaymentsofdebt": 5000000,
    "proceedsfromissuanceofcommonstockoptionsandcommonstockwarrants": 180000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 297000,
    "proceedsfromstockplans": 1260000,
    "paymentofofferingcosts": 327000,
    "netcashprovidedbyusedinfinancingactivities": -4184000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -120338000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 4975000,
    "interestpaidnet": 1049000,
    "capitalexpendituresincurredbutnotyetpaid": 270000,
    "embeddedinterestassociatedwithprogramfees": 3144000,
    "entityincorporationdateofincorporation": "April 21, 2003",
    "numberofoperatingsegments": 1,
    "unrestrictedcashcashequivalentsandmarketablesecuritiesatcarryingvalue": 133500000,
    "upfrontpaymentreceived": 60000000,
    "goingconcernperiodfromissuanceofunauditedinterimcondensedfinancialstatements": 12,
    "substantialdoubtaboutgoingconcernwithinoneyear": "false",
    "propertyplantandequipmentusefullife": "five years",
    "accountsreceivablenet": 1500000,
    "interestincomeexpensenet": -4350000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 4975000,
    "assetsfairvaluedisclosure": 128513000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 128348000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 168000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 3000,
    "availableforsalesecuritiesdebtsecurities": 128513000,
    "cashandcashequivalentsfairvaluedisclosure": 3151000,
    "marketablesecuritiesmaturityperiod": "one year",
    "availableforsalesecuritiescontinuousunrealizedlosspositionaccumulatedloss": 4500000,
    "contractwithcustomerliability": 800000,
    "newaccountingpronouncementorchangeinaccountingprincipleeffectofadoptionquantification": -10327000,
    "contractwithcustomerliabilityadditions": 2826000,
    "contractwithcustomerliabilityrevenuerecognized": -23012000,
    "revenueremainingperformanceobligation": 19500000,
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionperiod1": "twelve months",
    "milestonepaymentreceived": 1000000,
    "revenues": 2900000,
    "relatedpartytransactionotherrevenuesfromtransactionswithrelatedparty": 1100000,
    "unearnedrevenue": 7100000,
    "embeddedinterestassociatedwithupfrontpayment": 3100000,
    "ftefundingreceived": 3600000,
    "revenuerecognitionaggregatemilestonepaymentseligibletoreceive": 1600000000,
    "milestonemethodrevenuerecognitiondescription": "If one or more products from each of the target programs are developed for non-oncology or a single indication, the Company will be eligible for reduced aggregate milestone payments. In addition, the Company is eligible to receive tiered royalties ranging from mid-single digit to low teen percentages on the worldwide sales of any commercial products that may result from the collaboration.",
    "maximumamounteligibletoreceiveforeachproductdeveloped": 52500000,
    "increasedecreaseindeferredrevenue": 600000,
    "maximumcontributioninclinicaldevelopment": 6000000,
    "maximumaggregatepayment": 19500000,
    "researchdevelopmentandcommercializationagreementterminationperiod": 12,
    "researchdevelopmentandcommercializationagreementterminationdescription": "The LLS Agreement terminates upon the earlier of (a) ",
    "convertiblepreferredstockwarrantliabilityfairvalue": 100000,
    "propertyplantandequipmentgross": 43481000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 33848000,
    "debtinstrumentnumberofmonthlyinstallments": 24,
    "debtinstrumentpaymentterms": "The Term Loans mature on March 1, 2024 (the “Maturity Date”) and will be interest-only through March 1, 2022, followed by 24 equal monthly payments of principal and interest.",
    "debtinstrumentfrequencyofperiodicpayment": "monthly payments",
    "debtinstrumentinterestrateterms": "The Term Loans will bear interest at a floating per annum rate equal to the greater of (i) 8.07% or (ii) the sum of (a) the greater of (1) the thirty (30) day U.S. LIBOR rate reported in the Wall Street Journal on the last business day of the month that immediately precedes the month in which the interest will accrue or (2) 1.67%, plus (b) 6.40%",
    "interestpayablecurrentandnoncurrent": 400000,
    "debtinstrumentinterestrateduringperiod": 0.08720000000000001,
    "interestexpensedebt": 1100000,
    "amortizationofdebtdiscountpremium": 200000,
    "debtlongtermandshorttermcombinedamount": 9900000,
    "debtinstrumentmaturitydate": "March 1, 2024",
    "debtinstrumentinterestonlypaymentsmaturitydate": "March 1, 2022",
    "lesseeoperatingleaseoptiontoextend": "two three-year options to extend the lease term",
    "operatingleasesrentexpensenet": 3600000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 3771000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 3195000,
    "lesseeoperatingleaseliabilitypaymentsdue": 6966000,
    "minorityinterestownershippercentagebynoncontrollingowners": 0.11800000000000001,
    "commonstockownershippercentage": 0.055999999999999994,
    "commonstockvotingrights": "one vote per share",
    "commonstockcapitalsharesreservedforfutureissuance": 450000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 326542,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 131939,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 6.71,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 1100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 154900,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardvestingdatemonthandyear": "March 2023",
    "allocatedsharebasedcompensationexpense": 78000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 3700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 30000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.21,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 7500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 22500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 22500,
    "othernonoperatingincomeexpense": 153000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 370920,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 12.89,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 5.1,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 14.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 12.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y10M17D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y7M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 2119000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 1531000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.6304,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.8317,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0192,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0251,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 335799,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 114103,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 16238,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 13.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 11.45,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 12.46,
    "valuationallowancedeferredtaxassetchangeinamount": 12600000,
    "operatinglosscarryforwards": 75100000,
    "taxcreditcarryforwardamount": 11500000,
    "operatinglosscarryforwardsexpirationyear": 2030,
    "taxcreditcarryforwardexpirationyear": 2023,
    "operatinglosscarryforwardslimitationsonuse": "Events which cause limitations in the amount of net operating losses that the Company may utilize in any one year include, but are not limited to, a cumulative ownership change of more than 50%, as defined, over a three-year testing period.",
    "cumulativechangeinownershippercentage": 0.5,
    "periodforcumulativeownershipchange": "P3Y",
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 3800000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "taxcutsandjobsactof2017changeindeferredtaxassetsandvaluationallowance": -12300000,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.227,
    "effectiveincometaxratereconciliationtaxcredits": 0.049,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": -0.013000000000000001,
    "effectiveincometaxratereconciliationasc606adoptionpercent": -0.039,
    "effectiveincometaxratereconciliationotheradjustments": 0.02,
    "deferredtaxassetsoperatinglosscarryforwards": 31010000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 20098000,
    "deferredtaxassetsdeferredincome": 7680000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 3718000,
    "deferredtaxassetsfixedassets": 795000,
    "deferredtaxassetsgross": 63301000,
    "deferredtaxassetsvaluationallowance": 63301000,
    "unrecognizedtaxbenefits": 3783000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1005000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 17000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null"
  }
]